Brief: Dice Therapeutics Reports Third Quarter 2022 Financial Results

Dice Therapeutics

09/11/2022 21:42

Nov 9 (Reuters) - Dice Therapeutics Inc  DICE.O :
    * DICE THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND RECENT HIGHLIGHTS
    * COMPLETED $345 MILLION UPSIZED PUBLIC OFFERING PROVIDING
FUNDING
INTO 2026
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED
$266.6
MILLION AT SEPTEMBER 30, 2022
    * QTRLY LOSS PER SHARE OF $0.55
    * Q3 EARNINGS PER SHARE VIEW $-0.60 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9v85bM 
Further company coverage:  DICE.O 
 ((Reuters.Briefs@thomsonreuters.com;))